Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
NCT01882439
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
395
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriatic Arthritis
Interventions
DRUG:
Tofacitinib
DRUG:
Tofacitinib
OTHER:
Placebo
DRUG:
Tofacitinib
OTHER:
Placebo
DRUG:
Tofacitinib
Sponsor
Pfizer